Dates: 01/01/2021
31/12/2024
Topic: Tool
Project type: Preclinic
Theranostic
Project target: Prostate Cancer
Financing:
H2020-EU.1.3. – EXCELLENT SCIENCE – Marie Sk?odowska-Curie Actions
H2020-EU.1.3.3. – Stimulating innovation by means of cross-fertilisation of knowledge
Participating agents:
DESTINA GENOMICA SLNE
OPTOELETTRONICA ITALIA SRL
UNIVERSITA DEGLI STUDI DI CATANIA
UNIVERSITA DEGLI STUDI DI TRENTO
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
UNIVERSIDAD DE GRANADA
Keywords: prostate cancer; nanotechnology; RNA; liquid biopsy; Circulating cell-free ribonucleic acids; ODG Platform; testicular germ cell tumour
Countries: Spain; Italy; Netherlands
Project page: Access page
